drugset / Trial / NCT00939900

Efficacy of Zoledronic Acid in Preventing Collapse of the Osteonecrotic Femoral Head

NCT00939900

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to test the effect of zoledronic acid over 2 years in preventing early collapse and progression of joint dome depression (≥ 2 mm by X-ray) of the femoral head in patients with large (\> 30%: criteria according to Kim et al) nontraumatic osteonecrosis.

Timeline

Start
2009-07
Primary completion
2012-06
Completion
2012-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Zoledronic acid Other / unclassified 5 mg Intravenous

Indications